Gilead says it has ramped up production of remdesivir by 50-fold
Gilead Sciences Inc says it has ramped up production of its antiviral remdesivir and expects to produce millions of vials soon enough. The California-based pharmaceutical company announced in a statement on Thursday that it has increased supply by more than 50-fold since January. Officials say they expect to meet ‘real-time global demand’ beginning in October and … Read more